|Bid||1,491.50 x 175400|
|Ask||1,492.50 x 417900|
|Day's Range||1,486.00 - 1,501.00|
|52 Week Range||1,446.50 - 1,745.56|
|PE Ratio (TTM)||43.75|
|Earnings Date||Oct 25, 2017|
|Dividend & Yield||1.01 (5.25%)|
|1y Target Est||1,743.04|
Sir, Joining in the discussion about GlaxoSmithKline's new plans, I find chief executive Emma Walmsley's strategic thinking on research and development questionable. I suggest it shows the terrible consequences ...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to GlaxoSmithKline Plc Here are 5 ETFs with the largest exposure to GSK-GB. Comparing the performance and risk of GlaxoSmithKline Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
The drug would be the first such treatment in Europe.